Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
International Journal of Oncology|November 18, 2004
Antimetastatic and anticancer activity of S-1, a new oral dihydropyrimidine-dehydrogenase-inhibiting fluoropyrimidine, alone and in combination with paclitaxel in an orthotopically implanted human breast cancer modelMamoru Nukatsuka, Akio Fujioka, Fumio Nakagawa, et al.Japanese Journal of Cancer Research : Gann|August 1, 2002
Sensitivity of human cancer cells to the new anticancer ribo-nucleoside TAS-106 is correlated with expression of uridine-cytidine kinase 2Yuji Shimamoto, Katsuhisa Koizumi, Hiroyuki Okabe, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 14, 2007
[Benefits of TS-1 plus leucovorin combination therapy for colorectal cancer: evaluation of therapeutic effect of TS-1 and leucovorin combination therapy using rodent model fed a low folate diet]Hiroaki Tsujimoto, Sayaka Tsukioka, Katsuhisa Koizumi, et al.World Neurosurgery|December 31, 2020
Aggressive Intraoperative Cisternal Clot Removal After Clipping Aneurismal Subarachnoid Hemorrhage in Elderly PatientsTsutomu Yoshikane, Takeshi Miyazaki, Shinichi Yasuda, et al.Oncology Reports|March 28, 2015
Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenograftsHiroshi Tsukihara, Fumio Nakagawa, Kazuki Sakamoto, et al.Breast Cancer Research and Treatment|September 3, 2010
Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenograftsMamoru Nukatsuka, Hitoshi Saito, Fumio Nakagawa, et al.Cancer Science|October 5, 2019
Activity of TAS4464, a novel NEDD8 activating enzyme E1 inhibitor, against multiple myeloma via inactivation of nuclear factor κB pathwaysHiromi Muraoka, Chihoko Yoshimura, Rumi Kawabata, et al.Experimental and Therapeutic Medicine|September 13, 2012
Combination therapy using oral S-1 and targeted agents against human tumor xenografts in nude miceMamoru Nukatsuka, Hitoshi Saito, Fumio Nakagawa, et al.Cancer Science|April 6, 2020
Acquired resistance to trastuzumab/pertuzumab or to T-DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728Hiroki Irie, Rumi Kawabata, Yayoi Fujioka, et al.Journal of Neurosurgery. Case Lessons|January 31, 2023
Cerebral tumor embolism from thyroid cancer treated by mechanical thrombectomy: illustrative caseYuta Fujiwara, Kentaro Hayashi, Yohei Shibata, et al.Pageof 5